Viome Life Sciences key facts
- Operator of a biotechnology and healthcare company intended to prevent and reverse chronic diseases.
- Viome Life Sciences’s last known valuation is $415.4M.
- It has raised $235.4M across 2 recorded rounds; the latest was Early Stage VC ($25.4M) in Aug 2024.
- Notable investors include Khosla Ventures, Marc Benioff, Eastward Capital Partners, BOLD Capital Partners, SquareOne Capital — 20 tracked in total.
- Viome Life Sciences has filed 2 Form Ds with the SEC since 2022, most recently Aug 2024 ($25.4M sold to 44 investors).
- Status: Privately Held (backing).
Who backs Viome Life Sciences
20+- ·The complete investor list: 20 names
- ·Watch Viome Life Sciences: the Monday email on marks, rounds and moves
Viome Life Sciences funding rounds
2 roundsViome Life Sciences valuation
Viome Life Sciences's last known valuation is $415 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Viome Life Sciences raised?
Viome Life Sciences has raised $235 million in total; 2 of its rounds are on record. The largest on record was a $67 million later-stage round in Sep 2022; the most recent was a $25.4 million early-stage round in Aug 2024.
Viome Life Sciences has filed 2 Form Ds with the SEC since 2022, most recently in Aug 2024 ($25.4 million sold to 44 investors).
Viome Life Sciences investors
20 investors are on record for Viome Life Sciences, including Khosla Ventures, Marc Benioff, Eastward Capital Partners and BOLD Capital Partners. The early-stage round in Aug 2024 drew 44 investors.
About Viome Life Sciences
Operator of a biotechnology and healthcare company intended to prevent and reverse chronic diseases. The company digitizes the human body and its microbiomes on a molecular level using at-home clinical-grade tests, analyzed through proprietary ribonucleic acid sequencing technology, and decodes precise health insights and biomarkers of various chronic diseases using artificial intelligence and systems biology expertise, enabling healthcare providers to give personalized nutrition recommendations and precision supplements to their patients.
- Sector
- Healthcare
- HQ
- Bellevue, WA, United States
- Founded
- 2016
- Employees
- 160
- Website
- viomelifesciences.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Viome Life Sciences’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.